These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 25647234

  • 1. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [Abstract] [Full Text] [Related]

  • 2. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [Abstract] [Full Text] [Related]

  • 3. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA, Waldner H, Zagon IS, McLaughlin PJ.
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [Abstract] [Full Text] [Related]

  • 4. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
    Campbell AM, Zagon IS, McLaughlin PJ.
    Brain Res; 2012 Sep 07; 1472():138-48. PubMed ID: 22820301
    [Abstract] [Full Text] [Related]

  • 5. Elevated serum [Met5]-enkephalin levels correlate with improved clinical and behavioral outcomes in experimental autoimmune encephalomyelitis.
    Ludwig MD, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2017 Sep 07; 134():1-9. PubMed ID: 28647454
    [Abstract] [Full Text] [Related]

  • 6. Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
    Rahn KA, McLaughlin PJ, Zagon IS.
    Brain Res; 2011 Mar 24; 1381():243-53. PubMed ID: 21256121
    [Abstract] [Full Text] [Related]

  • 7. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ, McHugh DP, Magister MJ, Zagon IS.
    BMC Immunol; 2015 Apr 24; 16():24. PubMed ID: 25906771
    [Abstract] [Full Text] [Related]

  • 8. Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
    Campbell AM, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2013 Jan 24; 90():43-51. PubMed ID: 22985690
    [Abstract] [Full Text] [Related]

  • 9. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
    Zagon IS, Rahn KA, Bonneau RH, Turel AP, McLaughlin PJ.
    Brain Res; 2010 Jan 15; 1310():154-61. PubMed ID: 19931226
    [Abstract] [Full Text] [Related]

  • 10. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.
    J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550
    [Abstract] [Full Text] [Related]

  • 11. Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis.
    Patel C, Zagon IS, Pearce-Clawson M, McLaughlin PJ.
    J Neurosci Res; 2022 Feb 26; 100(2):551-563. PubMed ID: 34821408
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.
    Garay L, Gonzalez Deniselle MC, Sitruk-Ware R, Guennoun R, Schumacher M, De Nicola AF.
    J Neuroimmunol; 2014 Nov 15; 276(1-2):89-97. PubMed ID: 25200475
    [Abstract] [Full Text] [Related]

  • 13. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ludwig MD, Zagon IS, McLaughlin PJ.
    Exp Biol Med (Maywood); 2018 Feb 15; 243(4):361-369. PubMed ID: 29307283
    [Abstract] [Full Text] [Related]

  • 14. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar 15; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 15. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
    Garay LI, González Deniselle MC, Brocca ME, Lima A, Roig P, De Nicola AF.
    Neuroscience; 2012 Dec 13; 226():40-50. PubMed ID: 23000619
    [Abstract] [Full Text] [Related]

  • 16. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 13; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 17. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
    Bhasin M, Wu M, Tsirka SE.
    BMC Immunol; 2007 Jul 16; 8():10. PubMed ID: 17634104
    [Abstract] [Full Text] [Related]

  • 18. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
    Luz A, Fainstein N, Einstein O, Ben-Hur T.
    Exp Neurol; 2015 Nov 16; 273():234-42. PubMed ID: 26342755
    [Abstract] [Full Text] [Related]

  • 19. Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response.
    Cassiani-Ingoni R, Muraro PA, Magnus T, Reichert-Scrivner S, Schmidt J, Huh J, Quandt JA, Bratincsak A, Shahar T, Eusebi F, Sherman LS, Mattson MP, Martin R, Rao MS.
    J Neuropathol Exp Neurol; 2007 Jul 16; 66(7):637-49. PubMed ID: 17620989
    [Abstract] [Full Text] [Related]

  • 20. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.